In vitro studies revealed that PD-related Mortalin variants are associated with mitochondrial impairments, including morphological changes of mitochondria, increased reactive oxygen species production, and reduced mitochondrial membrane potential [16]. Here, HSPA9 is linked to Parkinson disease.